ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action
R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
Lancet: 10-20-30 targets to address AMR by 2030
UK to expand NHS Subscription Pilot! Consultation Period launches
Mirror Bacteria: An AMR threat of unprecedented magnitude
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Modeling the value of an effective antibiotic — Megiddo et al.
NIAID workshop: What is a robust PK-PD package?
In Praise of Non-Inferiority
FDA workshop: Insights on inhaled antifungals and antibacterials
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet